
    
      The study is designed as a randomized, double-blind label, interventional study on patients
      with T2DM. The eligible participants are randomly assigned to control and anthocyanins group.
      During the 24 weeks trial period, the participants are instructed to consume two anthocyanin
      capsules or placebo capsules twice daily (30 minutes after breakfast and supper).
    
  